Evidence map›Paper›PMID 35407234›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Recent Advances in Green Synthesis of Ag NPs for Extenuating Antimicrobial Resistance.

Simerjeet Parmar, Harwinder Kaur, Jagpreet Singh, Avtar Singh Matharu, Seeram Ramakrishna, Mikhael Bechelany

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simerjeet ParmarDepartment of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib 140406, India.
Harwinder KaurDepartment of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib 140406, India.
Jagpreet SinghDepartment of Chemical Engineering, Chandigarh University, Gharuan, Mohali 140413, India.ORCID 0000-0002-0424-047X
Avtar Singh MatharuDepartment of Chemistry, Green Chemistry Centre of Excellence, University of York, York YO10 5DD, UK.ORCID 0000-0002-9488-565X
Seeram RamakrishnaDepartment of Mechanical Engineering, Centre for Nanotechnology & Sustainability, National University of Singapore, Singapore 117575, Singapore.ORCID 0000-0001-8479-8686
Mikhael BechelanyInstitut Européen des Membranes, IEM, UMR 5635, University of Montpellier, ENSCM, CNRS, 34000 Montpellier, France.ORCID 0000-0002-2913-2846

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combating antimicrobial resistance (AMR) is an on-going global grand challenge, as recognized by several UN Sustainable Development Goals. Silver nanoparticles (Ag NPs) are well-known for their efficacy against antimicrobial resistance, and a plethora of green synthesis methodologies now exist in the literature. Herein, this review evaluates recent advances in biological approaches for Ag NPs, and their antimicrobial potential of Ag NPs with mechanisms of action are explored deeply. Moreover, short and long-term potential toxic effects of Ag NPs on animals, the environment, and human health are briefly discussed. Finally, we also provide a summary of the current state of the research and future challenges on a biologically mediated Ag-nanostructures-based effective platform for alleviating AMR.

Indexed as

antimicrobial resistanceenvironmentalgreen synthesissilver NP’s

Identifiers

PMID35407234
PMCPMC9000675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.